Prior authorization for GLP-1 medications is typically required regardless of plan type
This will depend on their overall health conditions, adherence to their weight management plan, and other factors
North America The GLP-1 Companion Products Hub The North America GLP-1 Companion Products Market will experience a steady growth rate in the short-term, mid-term, and long-term with the emphasis placed on the reduction of gastrointestinal side effects as well as the preservation of lean muscle mass, given the significant adoption of GLP-1 receptor agonists for weight management and type 2 diabetes care
Powell DR, Smith M, Greer J, Harris A, Zhao S, DaCosta C, et al
Understanding both categories is essential for informed decision-making and patient safety